Nocil Ltd
NSE:NOCIL
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
224.4
330.55
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Nocil Ltd
Earnings Call Analysis
Q2-2025 Analysis
Nocil Ltd
In Q2 FY '25, NOCIL Limited reported a revenue from operations of INR 363 crores, reflecting a marginal decrease from INR 372 crores in Q1 FY '25. Logistical challenges contributed to a slight volume dip sequentially, although year-on-year, volumes grew by 11%. The half-yearly performance shows total revenues at INR 735 crores compared to INR 748 crores in the same period last year, indicating a 2% decline. Despite external challenges, which include geopolitical tensions and freight cost increases, demand for rubber chemicals remains robust, particularly driven by the tire industry.
Operating EBITDA for Q2 FY '25 stood at INR 38 crores with margins around 10%, slightly down from INR 41 crores in Q1 FY '25. This decrease in margin was attributed to a 10% increase in production activity, leading to higher operational costs. Notably, the profit after tax for Q2 improved to INR 42 crores from INR 27 crores in Q1, partly due to a tax credit from budget changes. For the first half of FY '25, profit after tax stands at INR 69 crores compared to INR 61 crores for the same period last year.
Looking ahead to the second half of FY '25, management expressed optimism regarding volume growth, maintaining a positive trend with an expected improvement based on current customer contracts and market demand. They confirmed that a 9% volume growth was achieved in H1 and anticipated further sequential growth as logistic bottlenecks are resolved.
The company faces intense pricing pressure from competitors in China, Korea, and the EU due to aggressive pricing strategies and market dynamics. Management emphasized the importance of balancing pricing and volume to remain competitive. They are focusing on increasing operational efficiencies and are exploring options to reduce overall production costs while sustaining price stability in the face of rising raw material costs.
NOCIL is progressing on its capital expenditure plans with INR 250 crores allocated for its Dahej facility, expected to boost capacity by 20% by FY '27. This expansion aligns with strategic growth objectives aimed at enhancing customer relationships and efficiency. Furthermore, the company is actively investing in research and development to introduce specialized products that can better withstand market fluctuations and contribute to improved margins, targeting better profit margins through reduced dependency on traditional rubber chemicals.
The outlook for the rubber chemicals market appears cautiously optimistic. Management anticipates a gradual recovery in global demand, particularly in North America and improved export performance in the latex business. While there are no specific revenue growth guidelines, management aims to achieve a sequential increase in volumes on a quarterly basis, continuing the growth trajectory facilitated by long-term customer engagements and new product introductions.
You don't have any saved screeners yet
Ladies and gentlemen, good day. Welcome to the Q2 FY '25 Earnings Conference Call of NOCIL Limited. This conference call may contain forward-looking statements about the company, which are based on the beliefs, opinions and expectations of the company as on date of this call. These statements are not the guarantees of future performance and involve risks and uncertainties that are difficult to predict.
[Operator Instructions]
Please note that this conference is being recorded.
I now hand the conference over to Mr. V.S. Anand, Managing Director of NOCIL Limited. Thank you, and over to you, Mr. Anand.
Thank you. Thank you, Shlok, and good morning to everyone. I'd like to start by expressing my appreciation for your presence today. Joining me are Mr. P. Srinivasan, our Chief Financial Officer and our Investor Relations advisers from SGA. I hope you have all received our investor presentation. It is available on both the stock exchanges and our company website.
To start with, let me provide you with an overview of the company's performance for quarter 2 financial year '25. During this period, revenue from operations amounted to INR 363 crores. We witnessed a slight degrowth in volumes in quarter 2 financial year '25 sequentially compared to the preceding quarter, partially impacted by logistical challenges.
Having said that, we continue to build on our volumes year-on-year, both on a quarterly and half yearly basis. The domestic demand for Rubber Chemicals continues to remain robust on the back of the tire industry stable replacement volumes and recovery in exports. Aggressive pricing actions and product dumping by Chinese, Korean and EU rubber chemical players have put a significant strain on prices.
On the industry front, there was a temporary slowdown in compounding production due to the shortages in very high prices of natural rubber. The natural rubber prices have since begun easing and availability improving. The OE growth for tires is expected to moderate amid softened demand. The 2-wheelers are expected to fare relatively better while the commercial vehicle segment is impacted by moderation in demand amidst a high base.
On the export side, we have seen continued momentum in our international business growth. Despite global challenges such as geopolitical tensions, container shortages, issues in the Red Sea region and rising freight costs, we have made good progress in expanding our international presence, a result of our long-term strategic engagement with our customers and our focused efforts in gaining approvals.
The Latex business has been witnessing a mild recovery with improved exports of rubber gloves from ASEAN and this augurs well for us. In terms of raw materials, prices remained marginally higher during the quarter. Passing on these cost increases to customers have been challenging due to the fierce competition from China, Korea and EU. In response, we have adopted a judicious approach balancing price and volume amidst these ongoing challenges.
Our chemicals expansion program is progressing well at our Dahej site. This CapEx program that aligns with our strategic objectives for growth will enable us to continue to partner with our customers in their growth journey. We continue to work on improving our operational efficiencies with technology and infrastructure and at the same time, prioritizing eco-friendly practices from energy-efficient production methods to waste reduction technologies.
Looking ahead, while there continues to be an element of unpredictability in the external environment, we remain positive on our growth opportunities. We continue to focus on building our market strengths, deepening our customer relationships and leveraging our rubber chemical expertise to drive growth.
I shall pause for now. That's it from my side. I will now invite Mr. Srinivasan to provide an overview of our financial performance.
Thank you, Mr. Anand, and good morning to everyone. Now let's run through the consolidated financial highlights. On the sales volume turn on an index basis for Q2 FY '25 is 141, taking base of Q1 FY '20 as 100. On the revenue parameters, the net revenue from operations for Q2 FY '25 stood at INR 363 crores as against INR 372 crores in Q1 FY '25, a marginal degrowth as compared to the previous quarter.
For the half year, the net revenue from operations stood at INR 735 crores as against INR 748 crores recorded in H1 FY '24, again, a degrowth of 2%. We have maintained our selling prices largely for the quarter. Volumes for Q2 FY '25 grew by 11% year-on-year, but showed a slight decline on a quarter-to-quarter due to logistic issues. The international business continues to show our growth trajectory. For the first half of FY '25, the volumes reflected a strong growth of 9% as compared to H1 FY '24. Here, the domestic maintaining the growth trend as per the market trending and the export performing at a relatively higher double-digit growth.
On operating EBITDA performance, operating EBITDA for Q2 FY '25 stood at INR 38 crores as against INR 41 crores for Q1 FY '25 with EBITDA margins around 10% in Q2 FY '25. Operating EBITDA margins for the quarter were impacted due to increase in production activity by 10% on a sequential basis, which led to higher operating costs, along with certain freight costs incurred [indiscernible]. For the half year, operating EBITDA stood at INR 79 crores against INR 101 crores for H1 FY '24 with margins standing at 11%.
Coming to the PBT parameters, the PBT for Q2 FY '25 -- operating PBT for Q2 FY '25 stood at INR 32 crores as compared to INR 37 crores Q1 FY '25. H1 operating PBT stood at INR 69 crores as compared to INR 84 crores in H1 FY '24.
On the profit after tax, the profit after tax for Q2 FY' 25 stood at INR 42 crores as compared to INR 27 crores in Q1 FY '25. This is on account of the consequent to the budget '24 announcement wherein the long-term capital gains tax rate unremitted change. There is a tax credit of INR 14.89 crores was recognized due to the budget changes. For H1 FY '25, the profit after tax stood INR 69 crores as compared to INR 61 crores in H1 FY '24.
With this, we would like to open the floor for question answers.
[Operator Instructions]
The first question is from the line of Nirav from Anvil Wealth.
I have 2, 3 questions. First is you mentioned that there was increase in the production activity this quarter, but I think the sales was impacted due to the logistics issue. I think very well reflected in our stock changes also. So let's say that if there was no logistics issue and we were able to sell whatever we have produced this quarter, what would have been the sequential growth in the volumes in Q2?
So, Nirav, I would expect it would have marginally been higher than the previous quarter.
Got it. And are those logistic challenges behind us and could we see the production what we have clocked in second quarter that should start moving in the third quarter onwards plus the normalized volume growth which you mentioned last time that we are seeing every quarter some bit of volume increases through the contracts what we have negotiated with the customers. So if you can just help us out understanding how the volume trajectory is looking out in H2 of FY '25. So I think we have clocked something close to around 9% volume growth in H1. So if you can just help us understand some bit on the volume side, that would be helpful.
Yes, sure. So like we mentioned also on the previous calls, we see volume to develop positively. And also for the second half, we maintain that there should be an improvement from here on further going into the second half, at least at this point, when we look ahead, and clearly, with the volumes developing positively.
Got it. Because sir, last year, third quarter was a bit sluggish in terms of the volumes. So safe to believe that the current level of volumes, what we have been doing in -- on a quarter-on-quarter basis, there should be improvement on the base volume of H1, is the right understanding to do?
Yes, yes.
Got it. Sir, second question is on the competition part. I think you mentioned that there was intense pricing pressure due to competition from China, Korea and EU. So I just wanted to understand from you, like when the competition behaves in terms of the -- on the pricing side, do they work on the cost-plus basis like when the raw material prices starts coming down, they adjust their prices accordingly on a spot basis and change your prices because of which we also face a similar sort of pressure in getting our volumes to be placed.
So how do the competition behaving at this point of time in terms of pricing, a, and in terms of placing their incremental volumes in the market?
Yes. So I -- based on our experience, what we see and I can't specifically comment on how -- what the approach is. But by and large, I see that they start with the cost-plus kind of cost-related pricing, but then it tends to then also become very, very market-based depending on how the rest of the pricing in the market tends to play out. So then that kind of tends to put a downward pressure if there is a lowering of prices by some of the players. So that's how this is playing out. Everybody is trying to really grab volumes because there is lower demand in some of the markets.
We know that the Chinese economy as such, utilization levels are at a significantly lower level. So they are really looking to take those volumes. So sometimes they do take some -- I would put it as rational or irrational decision to take some volumes. And then that tends to put pressure on quite a few of the other players on the pricing.
Got it. So at some point of time, do the customers approach us also on the similar lines that do we also need to price our products on a cost-plus basis or adjust our price accordingly. So if you can just help us understand what sort of volumes of ours are susceptible to the spot prices and how much of our volumes are more towards the contracted side where such changes on a quarterly basis doesn't impact us?
Yes, it's a mix of both. So basically, like we have also explained in the previous calls, most of the pricing tends to hold for a quarter, at least with the large customers, some of them even for longer periods. But some of them, since they are also long-term relationships, they don't tend to fluctuate that much. Some of the customers -- and it's a balance of both, where we have the long-term engagement where you don't see too much of fluctuation in volumes from one quarter to the other. But for some of the other customers, you do tend to see this fluctuation. So it's a mix of -- a basket of both that we have, Nirav.
Got it. Sir, lastly from my side. One, you mentioned that there was a double-digit volume growth on the export side on a Y-o-Y basis. So if you can just clarify that number.
And second, are we seeing any recovery on the latex side of the business where our volumes were impacted in last year and even in first quarter. So are we seeing some sort of recovery there on the latex side of the business?
Yes. So on the latex, yes, there is -- we do see that the production of rubber gloves is improving. Partially, I think also what we see is that exports from ASEAN is also improving. So there is an uptick in the market compared to the situation last year for sure.
Got it. And sir, last one on the export numbers or export volume growth on a Y-o-Y basis, if you can clarify, sir.
Yes, it's double-digit growth only, confirm. We are -- I will not specify the exact number, but it is definitely more than double-digit growth.
The next question is from the line of Aditya Khetan from SMIFS Institutional Equities.
Sir, my first question is also the volume part. Sir, on sequential basis, sir, can you clarify the volume dip is majorly because of the international volumes or because of the domestic volume?
So there is growth on both fronts from a year-to-year basis. Also on a sequential -- we see there is a bit of a staggering of volumes is what I would say. It's not -- and due to logistical challenges that we have witnessed here. So I don't see that as a real degrowth per se.
Okay. Sir, on to the logistical challenges, so that is clearly reflected into the higher other expense. Sir, is it possible to quantify the number? How much was it higher on a sequential basis absolute figure, sir, if it is possible to share?
So like I mentioned, at least I think if we didn't have, hypothetically, we should have marginally been higher than the previous quarter volumes.
Okay. Sir, as you had also mentioned in your initial commentary that higher competition is clearly impacting the company. And that is also reflected into our per tonner margins, which we calculate. Sir, any idea like -- so in terms of a cycle, so that is clear so we are standing at the bottom. So what are the triggers like which can take this per tonne margins to the original levels, which were there, you can say, 5 to 6 years so before any triggers you find apart from the higher competition or any sort of the value addition, which is going up or any sort of new products we are launching, so that can help us to improve the margins or we will -- so more or less remain at this level going ahead?
I see that with improving of the economies outside of India and improving demand. We should see prices moving up. But then I don't have a specific time frame to put in terms of when this will improve given the uncertainties that are all around. But that's on the market front and where I see that there is clearly a possibility that prices should improve with increasing demand in the other markets.
But on the other hand, we continue to work on products which we can bring to the market, but they do take its time. We are in trial phases, products are in different stages, where we want to also I'll get into the products and applications where we can see more resilience. So that is work in progress, but that's still some time away.
Okay. But sir, in your presentation also, so the graph of the rubber consumption. So sir, that number is quite similar to the 2017 figures of 28 million tons. So it seems, sir, over a period of 6 to 8 years, so demand has been largely flattish only into the global market. Any particular reason, sir, why this demand has not gone up and it is at a similar level?
So Aditya, there are a few challenges, which the market encountered. One was the automobile degrowth in 2018, '19 in China. Second, the COVID waves of 1, COVID-1 or COVID-2, stuff like that, which has the impact on the consumption and other consumption. So therefore, if you see, there were 2 major interruptions during those periods where the market degrew and therefore, you saw a flattish thing. But whenever there is a recoup happening, it goes into 3% thereabout or 4% thereabout.
So it's a matter of time before we -- so once the stable -- conditions stabilize, I think, hopefully, the momentum will pick up. Having said that, in the last 10 years, one has seen despite this volatility, the average growth for this industry has been 2%, 1.8% or thereabout. So compounded CAGR growth is 2% per annum. Now maybe once these things specify, I think -- or correct -- the conditions stabilize, hopefully, the momentum starts to pick up.
Got it. Sir, just one last question. Sir, any update on the antidumping duty? Have you represented to the government? And is the government so seriously considering to import an antidumping duty in the near future, considering the impact which we have seen in our margins and all?
We are actually at the moment studying various parameters of the study. We have not filed anything.
Okay. So we have not applied yet, Sir?
Yes. We are studying this before we decide which product if at all if you want to. So for this study, we have to -- there are various parameters to be studied before we take a view. And this is a joint decision between our consultants and NOCIL. So at an appropriate as and when we do it, we'll announce it.
The next question is from the line of Radha from B&K Securities.
So firstly, I would like to appreciate the management and team for continuously increasing volumes despite the challenges. Sir, my question was on the other expense front. I was surprised to see the higher other expense in this quarter. So normally around 45% of other expenses power and fuel cost and 14%, 15% is freight. So in the previous con call, you have mentioned that from this quarter, we'll be witnessing the benefit of cogen turbine. So I thought that any increase in freight costs would have been offset by benefit of cogen. However, it was not reflected in the numbers. So I request you to kindly help me understand these numbers.
Radha, there are a few things. The turbine got commissioned in this quarter. It's a fact. We saw some benefits accruing. But what we -- I think what you missed is that we had a production increase in the activity because we had anticipated a higher sales dispatch during the quarter, which didn't happen. So therefore, the loading of expenses is there proportionate to the activity -- manufacturing activity. So that's one thing.
And secondly, we also had the exports to the destination in the Western world. So obviously, it will be having a relatively higher freight costs as compared to our Asian continent markets. So both these factors came into the system in terms of other manufacturing expenses or -- and which includes even the packing material also. So there are 3, 4 parameters, which got loaded in other expenses. That's why it's a onetime you see this, but it should stabilize as we go along.
All right, sir. So Sir, just continuing this point. So from July to October period, we have seen that freight rates have halved from $6,000 to $3,000. So in the next quarter, do we expect to see twin benefits of cogen plus lower freight rates in addition to the operating leverage on anticipation of higher volumes?
Yes, we are going to see that. Those things will come in.
All right, sir. Also, so I just wanted to ask that in the last quarter, we were expecting some large approvals from customers. So has that come through?
Yes, Radha. So this is ongoing, and we do receive on a quarterly basis approvals. So like I've mentioned, it's not specifically -- it will be a customer, multiple customers, multiple sites. So that's ongoing, and that is progressing from quarter-to-quarter.
Sir, when can you see those volumes reflected in the numbers?
So actually, we are seeing this. So as we speak, we are seeing this. And like we just discussed in one of the earlier questions, we are clearly seeing it in the volume development.
All right. And lastly, on the South America market, OE and aftermarket demand seems to be very strong. So I just wanted to know, are you supplying to this region? And any new customer addition or share of business increase with customers located in this region? Also today, volume in South America, if we take an index number of 100, then how much growth are you expecting from this region in the next 2 years?
So we are supplying to the South American market. We have presence with some of the global customers in those markets. Most of the growth, I expect more in North America than in South America because also the volumes and the opportunities are more there. So I -- we have not put a specific number on what we will expect from South America in the next few quarters as yet.
Sir, what percentage of our total volumes would be to South America? Would it be lower than 5%?
By and large, yes.
The next question comes from the line of Dhaval Shah from Girik Capital.
Sir, my question is on the commentary made for H2. Now the overall Auto market globally is -- the commentaries has been quite low and we see a good improvement for us in terms of volume growth. Now this is coming on back of you're seeing more customer wins on the specialty side and some market share gain. So where is this positivity coming out from? That's my first question.
And second question is on the competitive intensity. You mentioned a couple of countries name. Now this intensity and you've seen it many times in the past also. So the quantum of intensity, is it similar to some time in the past or it's something like very high right now? If you could relate to a time period in the past for us to better understand how we reacted that time and how did we come out of it. So some relation with the past. These are my 2 questions.
So let -- so the first part of your question, there are 2 things. One is, if look at our market share outside in India, we have a very negligible market share. That is one. So there is an opportunity to grow with customers. And the other part is when you look at the rubber industry consumption and largely it is the tire dominated. And within that, it's -- the OE part is a smaller percentage, right? It's about only 30%, very reflective of what we have in India and even in the global market. So it's more of a replacement market.
And I see that the replacement market is still reasonably doing better than last year when I see this across the regions. So that is also a positive trend. On the other hand, our presence is also small. So with both this as a combination, there is reason for optimism.
And the third part, which I can add is the long-term engagements that we've been having, the strategic engagements and the approvals that are coming through, which also I see as a positive contributor to that. So if I would summarize, I think these are some of the points to answer your first question.
The second one on the part of the intensity of competition. I would say it is at a high level now to really say is how related is it to some period in the past, yes, I'm sure that there has been a period similar to this in the past, some period around 2019, '20...
I think '20, '12, '13 also.
Yes, '12, '13. So there have been phases where this intensity has been high. So that's -- let's say, if I look at a time frame from the past, there are some comparisons to the similar period.
Okay. So between then and now, our portfolio mix is much better towards better margin products or specialty products, we may put it? Is it the right way to understand since we are always focusing in many years to improve our specialty portfolio outside India?
Yes. So they have increased over the years, but also some fluctuation here and there in the last 1 or 2 years. We see that, that has contributed also with some of the specialized application products increasing in volumes over the years. That has given us a lot more robustness to the bottom line.
Okay. Sir, any innovation index kind of metrics we maintain to understand out of our total sales volume as you do today, how much of the products have we developed in the last 3-year or a 2-year period? Just to understand how are we progressing as a company?
Yes. So we are tracking what's usually called with the Vitality Index and so which is critical to look at new products introduction and how they perform as an overall percentage of sales. We are tracking it, but we have not declared any of this in public domain. But to give you an idea, it is progressing positively. And so that's something that we have as part of our leadership dashboard that we watch very, very closely. So that's something that we track, so products introduced in the last 5 years.
Interesting. And last question, sir. As we see volume growth from basically the index, what we give, so this quarter, we were at 140-odd. Now like a 10% growth from here should give -- should bring a big leverage on the EBITDA. Is my understanding correct? Like if we just compare it, say, in FY '23 quarters. So is there like a large operating leverage sitting here for a 10% volume growth from here?
There will be operating leverages kicking in as the volumes go up for sure.
So can we look at like a 10% volume growth from here could give a 3%, 4% jump on the EBITDA side?
I think we cannot quantify those things at this moment. We are studying that because it all depends on the product mix also. So that's...
And is there a room to improve our gross margin further from here? I mean, keeping aside the price increases, which are market-driven but is there some like organic growth room to improve our GP, which we like 43% this quarter?
There is a continual improvement. We always work on our efficiencies and the yield parameters on a regular basis. So we start monitoring on a regular basis, and we do have an internal target where we can stretch ourselves. But it all comes under the broad chemistry composition of the structure of molecule. So I think we have some room to play, but I don't think it's that significant, but maybe a 1% here and there it can improve definitely.
And just to add, a lot of work of our R&D team, apart from looking at new products, is -- include process efficiencies and both on the yield as well as the process. So they continue to accrue, and I'm positive with volumes, they'll also add.
The next question is from the line of Rohit Nagraj from Centrum Broking.
Sir, first question is on the export recovery. So you mentioned that there is a recovery in exports and double-digit volume growth. At the same time, you have also mentioned that there have been aggressive pricing actions from China, Korea and EU players. So how have we fared in terms of these competition? And maybe which geographies which have given this kind of growth? Or is there anything which can be explained by these 2 contradictory things?
Thanks, Rohit. So I would say while -- yes, the competition and price intensity continues to be there, not only in India, but also outside, probably a bit more in India because people see that there is demand in the country. It's -- if I were to put it, it's a combination of the long-term engagements that we are getting into and the push over the last 2 to 3 years and the long-term relationship that we have had, which is enabling us to mitigate some of these other factors to a certain extent.
So I cannot say that we are immune to it surely. We also will be susceptible. But at least it's holding us in good stead. And we are positive that we should be able to at least continue in that direction more as a reliable supplier, a long-term supplier, somebody they can derisk their supply chains from. So that's -- these are things that are working positively, Rohit.
Sure, sure. Second question, sir, we've been talking that we want to derisk ourselves from the rubber chemicals. And probably, we've been working on the same in our R&D, but nothing has actually come out. So any progress on that? And given that there could be opportunities outside the current vertical that we are in, are we aggressively looking at any inorganic opportunities besides the CapEx program that we are having and given the cash balance is significantly higher on our balance sheet?
Yes. So it is a 2-pronged approach where we look to leverage adjacencies in our chemistry. That means how do we look at our own chemistries that can go to other applications. There is work that's happened and there has been some sales in that front, but really not so material for us to report it. These are very specialized applications also where we see some good traction. We've been working on these projects for more than 2, 3, 4 years now and some of them are showing some traction, but I'm really not in a position to really talk about it because I don't see it as so material, but hopefully, they will start gaining some traction.
On the other hand, the option is always to look at the inorganic. And we are actively looking at it. At the same time, we want to find an option that can also leverage our own strengths, strength not only in chemistry, but all a lot of our other capabilities that we have, we can actually then have those synergies coming together. We're working on this, and I'm also not able to put any time line to that because there are so many other factors that play into this that sometimes they don't work in the last minute. So I think that's ongoing. We will continue to pursue that.
Got it, sir. Sir, just one last clarification. The 20% increase in capacity from this INR 250 crores of CapEx, what is the time line for this? When is it likely to be commissioned?
That's like the third, fourth quarter of '20 -- so actually, Rohit, we have announced that by September '26, 30 months from the date of announcement, we'll be ready with the plant ready for completion. Thereafter, the trials and approvals thereafter. So it may take 3, 4 months thereafter. So that's why you said fourth quarter of FY '27, the business should start coming in.
The next question is on the line of Raman [ KV ] from Sequent Investments.
Can you hear me, sir?
Yes, Raman.
Sir, can you give the guidance for FY '25 as well as what's the current capacity utilization?
So current capacity utilization is 70%.
70%.
And our guidance in terms of volume, we -- as we have said in the past, and again, we maintain, we will -- our endeavor is to grow sequentially quarter-over-quarter. So we don't want to give any specific guidance. Our intention, the base number is 140, we would like to grow from here every quarter.
Okay. In terms of volume, you want to grow quarter-on-quarter.
Yes, yes, that's what we are looking at.
And sir, you have announced INR 250 crores CapEx for the Dahej facility. So is the whole CapEx for -- only for debottling the existing facility? Or are you planning to addition...
It's a brownfield new plant. It's not a debottlenecking project.
It's a brownfield project.
Yes, that's right.
And sir, you have told in this call itself that the specialized products gave more robustness to the company's finances as well as you have mentioned that there are new products under development. So these products, are they like a specialized chemical products? Or they are just like, how do I say, low-margin products?
Yes. So -- what I mentioned was over the years, the specialized applications have slightly moved up but not beyond a certain point. There was -- not specifically to this quarter to the previous quarter, nothing has significantly changed on the specialized application products. Coming to our new developments, clearly, the focus is on better margin products, less on the commodity space.
The next question is from the line of Manoj [ Jethva ] from KSA Shares and Securities Private Limited.
So my first question is relating to the green chemistry, which you have mentioned in the presentation slides. So currently, NOCIL is having 20-plus product applications. So are we going to launch any new products keeping in mind the green chemistry in mind?
Yes. We are working on this. So when you say green chemistry, it also includes substances that are safe to use as well as looking at greener renewable options. So all these are -- we're looking at all this regularly, and they are in the works, Manoj.
Sir, my second question is pertaining to China +1 strategy. So everybody is talking on the buzzword of China +1 strategy, China +1 strategy but China is also coming out with the new economic package of almost around $54 billion. So how we got trails against such developments which might take place in China?
Yes. So when you say the China +1 strategy and it's -- if you really bottom line that, it's nothing about reducing your supply chain risk, right? And as a player, as a large, if I put myself in the shoes of any of our customers who buy something that is very dependent on ingredients that run their plant, I'm always looking to derisk my supply chains to ensure that I have a stable supply chain. And this obviously leads to opportunities for players who can support them in this front.
So I see that this supply chain derisking will continue to gather momentum with all the uncertainties that are around. So I see that this will gain more traction as we go along. I'm not able to comment on the stimulus or what's really happened there. But I think the fundamental comfort is to look at supply chain derisking.
So just to add a bit, I think the -- despite the stimulus, what you have seen is the export tax subsidy, which the Chinese government has extended to the rubber chemical manufacturers continues to remain at the same level. It has not been increased.
Sir, I appreciate to share some growth trajectory apart from the rubber chemical things. Are we looking out for any inorganic growth in the same space, either, say, in India or overseas?
We are exploring options, Manoj, like I responded to one of the earlier questions. That's an ongoing process. We are doing it in a structured manner, and that's ongoing.
The next question is from the line of Nirav from Anvil Wealth.
When I see your annual report and in particularly, the power schedule, and when we compare our volumes of FY '22 and similar amount of power consumption, I think what we have consumed in terms of per metric ton of finished goods was something around close to 5,500 units, which is now down to 5,000 units, precisely in FY '24. So this is despite of the fact that our volumes have not grown, but we have bring down our per ton consumption of power. So one thing you mentioned that we have been continuously investing in the process part of our business.
So 2 things here: one, with the improvement in the volumes, which we are envisaging, could this further fall -- and specifically, I'm talking about the power consumption per metric ton of finished goods and with the turbine benefits also now accruing to us, would it also bring it down our unit cost of power because predominantly, we were more reliant on the coal side and with this renewable power coming on. So just wanted to understand the benefit of this in light of volume growth, a, and the mix of power getting changed?
Yes, we will see some benefits accruing in. I think because some things marginally got kicked in, in this quarter because we commissioned during the quarter. So as we go along and once it starts operating at a stable capacity, these benefits will start accruing in.
Got it. But sir, is it the right understanding that our power consumption per metric ton has come down by close to 10% over the last 2 years, and this is purely because of the process part of our investments?
So what happens is whenever you are running a plant at a particular throughput rate or a better utilization rate, you will get the optimization benefits, some of those...
Got it. And this should further improve once our volumes getting ramped up?
Yes, Nirav, that's expected to happen. And also the fact that we've been also looking at green energy options, that's also been contributing to that with the ramp-up.
Got it. Sir, secondly, apart from the power side, are we seeing any improvement on the per unit consumption of raw material or, let's say, improvement in the input output norms for some of our products where you mentioned that the process innovation is also being a key investment for us. So are we seeing some improvement there also, which eventually brings down our cost of production?
Yes. So we have several examples internally where we have had this. And over the years, this is a continual program. And regularly, there is work on the yields, on the consumption of the raw materials. So there is positive traction on this on a regular basis, Nirav.
Correct. Sir, last from my side is in terms of the debottlenecking what we have been doing, how much would have been capitalized in H1 of FY '25? And how much balance is yet to be capitalized?
Nirav, I don't have specific numbers right now with me. As and when I get the details, maybe I'll share it separately with SGL at a later date.
As there are no further questions, I would now like to hand the conference over to Mr. Anand for closing comments.
Thank you. Thanks, Shlok, and thank you, everybody, for your time and engaging discussion. I take this opportunity to thank everyone for joining the call. I hope we've been able to address all your queries. For any further information, kindly get in touch with me or Strategic Growth Advisers or Investor Relations Advisers. We wish you all a happy and safe Diwali and a Happy New Year. Thank you once again, and have a nice day.
Thank you. On behalf of NOCIL Limited, that concludes this conference. Thank you for joining us, everyone, and you may now disconnect your lines.